哈德森和汤姆谈话
AbbVie首席科学官
manbet体育网址我们的科学:首先,更快,对病人
At AbbVie, our R&D teams are chasing bold goals. The therapies and solutions that no one else has achieved or even attempted. And we want to be there first. That's what we go after every day for our patients.\r\n"}}" id="text-4be7f63a99" class="cmp-text">
在AbbVie,我们的研发团队正在追逐的目标。治疗方法和解决方案,没有其他人取得甚至尝试。我们想第一。这就是我们每天为我们的病人。
我们的研究和开发方法狗万正网地址
Science and innovation are the lifeblood of our company. From drug discovery to clinical trials to regulatory approval, we're pursuing new ways to address patients' most challenging health issues.
\r\n
\r\nSince our launch in 2013, we've invested more than $50 billion in R&D. This enables us to discover and deliver innovative medicines and products that solve serious health issues, enhance people's lives today, and address tomorrow's medical challenges.
\r\n
\r\nWe focus on core areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs. These areas are oncology, immunology, neuroscience, eye care, medical aesthetics and other specialty areas. \r\n"}}" id="text-1a33fc327d" class="cmp-text">
\r\n
\r\nSince our launch in 2013, we've invested more than $50 billion in R&D. This enables us to discover and deliver innovative medicines and products that solve serious health issues, enhance people's lives today, and address tomorrow's medical challenges.
\r\n
\r\nWe focus on core areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs. These areas are oncology, immunology, neuroscience, eye care, medical aesthetics and other specialty areas. \r\n"}}" id="text-1a33fc327d" class="cmp-text">
科学和创新是我们企业发展的命脉。manbet手机版登录从药物发现到临床试验监管部门的批准,我们寻求新的方法来解决病人的最具挑战性的健康问题。
自从我们在2013年发射,我们投资了超过500亿美元的研发。这使我们能够发现并交付创新药物和产品,解决严重的健康问题,提高人们的生活今天,明天和地址的医疗挑战。
我们专注于核心领域知识和大胆的思维具有最大的潜力来解决未满足的需求。这些区域肿瘤学、免疫学、神经科学、眼部护理、医学美学等专业领域。
里面看的肉毒杆菌®(onabotulinumtoxinA)
In this episode of Discovery Files, we hear the origin story of this medication from AbbVie’s Mitchell Brin, M.D., SVP of R&D and Chief Scientific Officer for BOTOX® and neurotoxins. \r\n
Please see BOTOX® full Product Information, including Boxed Warning and Medication Guide.
\r\nPlease see BOTOX® Cosmetic full Product Information, including Boxed Warning and Medication Guide.
\r\n"}}" id="text-f4e443e21a" class="cmp-text">在这节课中发现的文件,我们听到这个药物的起源故事AbbVie米切尔的林,医学博士研发的高级副总裁和首席科学官 ®和肉毒杆菌神经毒素
请参阅肉毒杆菌®完整的产品信息,包括警告信息和用药指南。
请参阅肉毒杆菌®化妆品完整的产品信息,包括警告信息和用药指南。
发现文件:
onabotulinumtoxinA
人
To develop innovative medicines, you need innovative people. Our teams collaborate across disciplines to connect people and ideas, fueling a culture of curiosity and problem-solving. \r\n"}}" id="text-9cc8b54b93" class="cmp-text">
开发创新药物,需要创新的人。我们的团队跨学科协作连接人与思想,推动文化的好奇心和解决问题。
管道
Our R&D work fuels a dynamic and diverse pipeline that continues to advance and deliver medicines and solutions for patients.\r\n"}}" id="text-f2806fe8e8" class="cmp-text">
我们的研发工作燃料不断进步的动态和各种管道,为病人提供药物和解决方案。
性能
The need to do more for patients motivates our R&D work. By investing in boundary-pushing approaches, we aim to advance programs with a stronger probability of success and move assets forward faster.\r\n"}}" id="text-278aed1c99" class="cmp-text">
需要为病人做更多激励我们的研发工作。通过投资不断突破的方法,我们的目标是推进项目与更强的成功概率和资产向前移动得更快。
全球思想家的一个社区
To develop innovative medicines, you need innovative people — lots of them. We have robust teams of biologists, chemists, clinicians, mathematicians, data scientists, engineers, and others working side by side with colleagues in regulatory affairs, patient safety, manufacturing and more. Our teams collaborate across disciplines to connect people and ideas, fueling a culture of curiosity and problem-solving. \r\n"}}" id="text-b106cf1fc3" class="cmp-text">
开发创新药物,需要创新的人很多。我们有强大的团队的生物学家、化学家、临床医生、数学家,数据科学家,工程师,和其他法规事务工作与同事并肩,患者安全、制造等等。我们的团队跨学科协作连接人与思想,推动文化的好奇心和解决问题。
参与
Interested in joining our team of innovative scientists and researchers?\r\n"}}" id="text-2cfb7637f8" class="cmp-text">
有兴趣加入我们的团队创新的科学家和研究人员?
外部链接
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.\r\n
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
\r\n"}}" id="text-942a86a5fd" class="cmp-text">除非另有规定,所有产品名称出现在本网站商标或许可AbbVie Inc .旗下的子公司或分支机构。没有使用任何AbbVie商标,商号,或贸易服装在这个网站可能没有AbbVie Inc .的事先书面授权,除了确定公司的产品或服务。
版权©2023 AbbVie Inc .北芝加哥,伊利诺斯州,美国
